Безопасен ли symphytum officinale root extract при беременности?

Pregnancy-safe products containing symphytum officinale root extract

glossier

Milky Jelly Cleanser

100/100

Безопасные альтернативы symphytum officinale root extract при беременности | VeriMom

Related ingredients

Frequently asked questions

Безопасен ли symphytum officinale root extract при беременности?

Symphytum officinale (comfrey) root/leaf extracts contain pyrrolizidine alkaloids (PAs) that are hepatotoxic, genotoxic and associated with carcinogenicity and reported fetal/veno‑occlusive effects; regulatory bodies caution against internal use in pregnancy and some authorities advise avoiding topical use in pregnancy because of PA-related risks (EMA monograph; PubMed reviews). Skin‑permeation studies show PAs are poorly absorbed through intact human skin but measurable, so topical exposure is low but not zero. (Sources: EMA herbal monograph; PubMed review of Symphytum species; human skin permeation study).

Безопасен ли symphytum officinale root extract при грудном вскармливании?

Because PAs in comfrey are hepatotoxic and have been implicated in infant toxicity and are discouraged during lactation, breastfeeding is cautioned; dermal/topical exposure can result in measurable but low absorption and there are case reports and regulatory warnings advising avoidance with nursing due to risk to the suckling infant. Mechanism is PA metabolic activation with genotoxic/hepatotoxic effects. (Sources: EMA monograph; regulatory advisories; PubMed reviews).

Безопасен ли symphytum officinale root extract для кожи малыша?

Infants (0–3 yr) have higher skin permeability and higher surface‑area‑to‑weight, so exposure score is increased. Given comfrey’s content of pyrrolizidine alkaloids (hepatotoxic/genotoxic), and documented infant/fetal cases and regulatory cautions (including advice to avoid use on nursing mothers and infants), residual PA on skin or transfer via breast/chest application could pose risk; although dermal PA absorption was shown to be low in one ex vivo study, infant susceptibility and cases justify conservative approach. (Sources: PubMed review; skin permeation study; regulatory guidance).

Как VeriMom оценивает symphytum officinale root extract?

VeriMom оценивает symphytum officinale root extract в 40/100 (средний риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы symphytum officinale root extract при беременности?

См. наш список безопасных альтернатив symphytum officinale root extract с аналогичной функцией и классификацией без известных рисков.